Who to call at Kernal Biologics, and when
Fundz watches for the moments Kernal Biologics starts buying, and tells you who to reach.
- An alert the day Kernal Biologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kernal Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kernal Biologics. With Fundz connected, it knows.
Kernal Bio Establishes Partnership with IFLI to Advance KR-402 for Follicular Lymphoma Treatment.
Contract Type
partnership
Description
Kernal Bio announces a strategic partnership with the Institute for Follicular Lymphoma Innovation (IFLI) to support the development of KR-402, a treatment for follicular lymphoma. This collaboration includes an investment aimed at accelerating preclinical development and brings new leadership appointments.
Quick answer
Kernal Bio Establishes Partnership with IFLI to Advance KR-402 for Follicular Lymphoma Treatment. (November 17, 2026). Kernal Biologics is based in Cambridge, Massachusetts, United States.
- What agreement did Kernal Biologics announce on November 17, 2026?
- Kernal Bio announces a strategic partnership with the Institute for Follicular Lymphoma Innovation (IFLI) to support the development of KR-402, a treatment for follicular lymphoma. This collaboration includes an investment aimed at accelerating preclinical development and brings new leadership appointments.
- What does Kernal Biologics do?
- Kernal Bio is a venture-backed therapeutics company engineering cells inside the body using AI-designed, selective mRNA and targeted LNP technology.
- Where is Kernal Biologics based?
- Kernal Biologics is based in Cambridge, Massachusetts, United States.
- Which similar companies announced agreements around the same time?
- Aarvik Therapeutics (November 3, 2026), Ocugen (November 10, 2026), AbbVie Inc. (November 3, 2026) and Cognito Therapeutics (October 27, 2026) also announced agreements within 45 days of Kernal Biologics.
Source: Fundz verified event record.
Other recent agreements in Healthcare and research
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Aarvik Therapeutics Enters Partnership with Laurus Labs for MUTTA™ ADC Development in India. (November 3, 2026)
- Ocugen Enters Exclusive License Agreement with Celairis Therapeutics (November 10, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- Rhode Island Life Science Hub and Cognito Therapeutics launch partnership for Alzheimer's research. (October 27, 2026)
- NeOnc Technologies Signs MoU with Abu Dhabi Department of Health (October 16, 2026)
- Evotec receives $2.9m grant from Gates Foundation to enhance stem cell-based drug safety testing. (November 17, 2026)
Related People
Agreement Insights
What this usually meansKernal Biologics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.